Sotera Health (NYSE:SHC) Receives Average Rating of “Hold” from Analysts

Shares of Sotera Health (NYSE:SHCGet Rating) have been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $17.56.

A number of equities research analysts have issued reports on SHC shares. Barclays raised shares of Sotera Health from an “underweight” rating to an “overweight” rating and lifted their target price for the company from $6.00 to $22.00 in a research note on Tuesday, January 10th. Royal Bank of Canada cut their price target on shares of Sotera Health from $25.00 to $8.00 and set an “outperform” rating on the stock in a report on Thursday, November 3rd. The Goldman Sachs Group cut their price target on shares of Sotera Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a report on Wednesday, November 23rd. TheStreet downgraded shares of Sotera Health from a “c-” rating to a “d” rating in a report on Monday, September 19th. Finally, JPMorgan Chase & Co. cut their price target on shares of Sotera Health from $9.00 to $6.00 and set an “underweight” rating on the stock in a report on Thursday, November 3rd.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. raised its holdings in Sotera Health by 7.6% in the 1st quarter. BlackRock Inc. now owns 6,252,520 shares of the company’s stock worth $135,429,000 after acquiring an additional 439,762 shares during the period. Boston Partners increased its holdings in shares of Sotera Health by 243.2% during the 3rd quarter. Boston Partners now owns 3,109,343 shares of the company’s stock worth $20,997,000 after purchasing an additional 2,203,400 shares during the period. State Street Corp increased its holdings in shares of Sotera Health by 1.8% during the 3rd quarter. State Street Corp now owns 2,562,979 shares of the company’s stock worth $17,480,000 after purchasing an additional 44,230 shares during the period. Cubist Systematic Strategies LLC increased its holdings in shares of Sotera Health by 3,594.8% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 1,378,845 shares of the company’s stock worth $9,404,000 after purchasing an additional 1,341,526 shares during the period. Finally, Two Sigma Investments LP bought a new position in shares of Sotera Health during the 3rd quarter worth about $7,422,000. Institutional investors own 87.21% of the company’s stock.

Sotera Health Trading Down 0.3 %

Shares of NYSE:SHC opened at $18.23 on Friday. The firm has a fifty day moving average of $8.74 and a two-hundred day moving average of $12.23. The firm has a market capitalization of $5.14 billion, a P/E ratio of 41.43 and a beta of 1.30. Sotera Health has a 12-month low of $5.78 and a 12-month high of $24.90. The company has a quick ratio of 2.74, a current ratio of 3.00 and a debt-to-equity ratio of 2.97.

Sotera Health (NYSE:SHCGet Rating) last issued its earnings results on Wednesday, November 2nd. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $248.70 million during the quarter, compared to analyst estimates of $245.66 million. Sotera Health had a net margin of 12.30% and a return on equity of 40.42%. On average, equities analysts expect that Sotera Health will post 0.89 EPS for the current fiscal year.

About Sotera Health

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Further Reading

Analyst Recommendations for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.